Acronym:
CS1002-101
ACTRN/NCT /ethics:
NCT03523819
Scientific title:
AND RADIATION THERAPY IN PATIENTS WITH HIGH RISK
Summary of trial and patient characteristics
| Cancer Type | All cancers | ||
|---|---|---|---|
| Trial Type | Treatment | ||
| Phase | Phase I | Tumour Stream | Solid Tumours |
| Age Range | 18 years and older | Cancer Stage | Locally Recurrent or Locally Advanced, Metastatic or Widespread |
| Sex | Both | Anticipated Start Date | 2018-05-01 |
| Molecular Target | Anticipated End Date | 2022-01-01 | |
| Cancer Type | All cancers |
|---|---|
| Trial Type | Treatment |
| Phase | Phase I |
| Age Range | 18 years and older |
| Sex | Both |
| Molecular Target | |
| Tumour Stream | Solid Tumours |
| Cancer Stage | Locally Recurrent or Locally Advanced, Metastatic or Widespread |
| Anticipated Start Date | 2018-05-01 |
| Anticipated End Date | 2022-01-01 |
Trial Summary
AND RADIATION THERAPY IN PATIENTS WITH HIGH RISK
Lay Summary
AND RADIATION THERAPY IN PATIENTS WITH HIGH RISK
Sponsor / Cooperative group
Cstone
Participating Hospitals
| Hospital | Clinical Trial Coordinator | Phone | Principal Investigator | Recruitment Status | |
|---|---|---|---|---|---|
| Ashford Cancer Centre Research | Sue Yeend | syeend@adelaidecancercentre.com.au | 08 8292 2240 | Dr Sarwan Bishnoi | Recruiting |